O-GlcNAcylation and cardiovascular disease.

Wright, JaLessa N; Collins, Helen E; Wende, Adam R; Chatham, John C

Wright, JaLessa N; Collins, Helen E; Wende, Adam R; Chatham, John C.

Afiliação

Wright JN; Division of Molecular and Cellular Pathology, Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, U.S.A.
Collins HE; Division of Molecular and Cellular Pathology, Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, U.S.A.
Wende AR; Division of Molecular and Cellular Pathology, Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, U.S.A.
Chatham JC; Division of Molecular and Cellular Pathology, Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, U.S.A. jchatham@uabmc.edu.

Biochem Soc Trans ; 45(2): 545-553, 2017 04 15.

Article em En | MEDLINE | ID: mdl-28408494

Assuntos

Acetilglucosamina/metabolismo; Doenças Cardiovasculares/metabolismo; Proteínas/química; Animais; Diabetes Mellitus/metabolismo; Regulação da Expressão Gênica; Glicosilação; Humanos; Processamento de Proteína Pós-Traducional; Transdução de Sinais

Palavras-chave

O-GlcNAc; cardiac hypertrophy; cardiovascular physiology; diabetes; ischemia; myocardium

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Acetilglucosamina / Doenças Cardiovasculares / Proteínas Limite: Animals / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google